Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Chlorthalidone (12.5mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)
Overview Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER
The extended-release combination medication, Sartelbeta Plus 12.5mg/50mg/40mg tablets, treats hypertension (high blood pressure). Its mechanism involves vasodilation (blood vessel relaxation) and improved cardiac pumping efficiency, also promoting fluid and electrolyte excretion. Sartelbeta Plus may be administered with or without food, but consistent timing optimizes effectiveness. Diuretic effects necessitate daytime dosing, ideally four hours before sleep, to minimize nocturnal urination. Dosage and frequency are determined by your physician based on individual needs and should be adhered to throughout the prescribed duration. Common side effects include nausea, diarrhea, gastrointestinal discomfort, headache, and lightheadedness. Regular monitoring of renal function and electrolyte levels is crucial. Optimal outcomes require concurrent lifestyle modifications, including balanced nutrition, regular physical activity, and smoking cessation. Increased fluid intake is recommended to counteract potential dehydration. Prior to commencing therapy, disclose any pregnancy, circulatory disorders, hepatic or renal impairments, and all other medications to your doctor, as interactions can affect efficacy or alter the drug's action.
Uses of Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER
Elevated blood pressure
Major Benefits of Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Sartelbeta Plus 12.5mg/50mg/40mg Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or divide it. While consumption with or without food is acceptable, maintaining a consistent administration time is recommended.
Common Side effects of Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER:
- Nausea
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Cold extremities
- Numbness of extremity
- Increased blood lipid level
- Slow heart rate
- Decreased blood pressure
How to use Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sartelbeta Plus 12.5mg/50mg/40mg Extended-Release Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
How Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER works:
Chlorthalidone, a diuretic, facilitates the urinary excretion of excess fluid and select electrolytes. Its long-term effects include vasodilation and enhanced circulation. Metoprolol succinate, a beta-adrenergic blocking agent, reduces cardiac activity by decreasing heart rate. Telmisartan, an angiotensin receptor blocker, lowers blood pressure through the inhibition of angiotensin, promoting vascular relaxation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Sartelbeta Plus tablets (12.5mg/50mg/40mg) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Sartelbeta Plus tablets (12.5mg/50mg/40mg) are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Sartelbeta Plus 12.5mg/50mg/40mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when taking Sartelbeta Plus 12.5mg/50mg/40mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally not recommended for individuals with such conditions.
LiverCAUTION
Patients with liver impairment should use Sartelbeta Plus 12.5mg/50mg/40mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER :
Should you forget a dose of Sartelbeta Plus 12.5mg/50mg/40mg Extended-Release Tablet, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sartelbeta Plus 12.5mg/50mg/40mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



